Month: April 2021

Vaccitech Announces Pricing of Initial Public Offering

Oxford, UK - Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced...

Associate Scientist Viral Vector QC

Due to exciting expansion across the company, with offices in the UK (headquarters), USA, Italy and Australia, Vaccitech is now recruiting for a Associate Scientist, Viral Vector QC, which is an laboratory-based role in the UK on a full time basis (37.5 hours per...